Indian capital adds 10 new cases of Omicron amid rise in infections
New Delhi, Dec 17 (EFE).- The Indian capital Friday reported 10 new infections of the Omicron coronavirus variant amid an alarming hike in daily Covid-19 cases.
Thus, the total number of people infected with the Omicron variant has risen to 20 in Delhi alone, with 90 cases of the strain reported nationwide, city Health Minister Satyendar Jain said in a statement.
At the same time, Delhi has begun seeing an increase in overall caseload, touching 90 infections a day after weeks of nearly 50 cases.
The national capital recorded nearly 90 fresh Covid-19 cases Thursday, the highest in more than four months.
The city had recorded 85 infections cases on Aug.10.
The city registered 57 Covid-19 cases on Wednesday, 45 on Tuesday, 30 on Monday, 56 on Sunday, and 52 on Saturday.
However, the new cases have not strained the city’s healthcare system.
But the rise has triggered an alert and marks a reversal in the sustained recovery curve after a devastating second wave that led to more than 400,000 infections and more than 4,000 deaths daily in May.
The Indian capital, one of the hardest hit by the rapid spread, saw its healthcare overloaded that left dramatic images of crowded hospitals and crematoriums amid a severe shortage of medical oxygen and medicines.
The country of more than 1.35 billion people now has added 7,447 new cases, maintaining the average of the last weeks.
On Tuesday, the country, for the first time in 19 months, reported fewer than 6,000 infections.
In the past 20 days, India has gone from two to 90 cases of the new variant first detected in South Africa.
Although India suspended international commercial flights in March 2020, bilateral agreements, known as air transport bubbles, with about 20 nations, have allowed limited arrival and departure of flights.
The vaccination campaign has administered 1.35 billion vaccines since it began in January. More than 530 million people have already received two doses of the anti-covid vaccine.
India has a vaccine-eligible population of about 950 million people. EFE
igr-ssk
